To further explore how mutant DYNC1H1 increase drug sensitivities of MTIs, we used a differential analysis method to identify mutant DYNC1H1 related genes by comparing DYNC1H1 mutated tumor with wild type tumors (37/338) in TCGA-STAD. The gene discussed is DYNC1H1; the disease is neoplasm.